ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β‑catenin signaling pathway.
Chen QF, Shi F, Huang T, Huang C, Shen L, Wu P, Li W. Oncol Rep. 2020 Oct; 44(4):1425-1440. Epub 2020 Jul 24.